Home / Business and Economy / Relay Therapeutics CFO Sells Shares Worth Millions
Relay Therapeutics CFO Sells Shares Worth Millions
30 Jun
Summary
- CFO Thomas Catinazzo sold 187,163 shares of Relay Therapeutics stock.
- The transaction occurred on June 22, 2026, for approximately $3.17 million.
- The sale reduced his direct holdings by over 51% but left him with outstanding options.
Relay Therapeutics Chief Financial Officer Thomas Catinazzo engaged in a notable stock transaction on June 22, 2026. He exercised options and subsequently sold 187,163 shares of the company's Common Stock. The sale realized an estimated $3.17 million based on the day's trading price.
This sale represented a considerable reduction in Catinazzo's directly held shares, decreasing his stake by 51.33%. Following the transaction, his direct holdings went from 364,624 to 177,461 shares.
However, Catinazzo maintains significant equity participation through 223,440 outstanding stock options. This includes both vested and unvested awards, offering potential future upside. The transaction is characterized as a periodic liquidity event, consistent with past behavior, rather than a change in investment strategy.
